Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do you think CHUC has a “CHEAP” stock price? Not when there are (WAY) more than 20 BILLION shares outstanding! CHUC’s market cap is VERY EXPENSIVE today. $.0025 (1/4 penny) is a fair price for CHUC; that’s a $50 million market cap… Pumpers are trying to get us to pay WAY MORE. Don’t be a BAGHOLDER!
CHUC has more than 20 BILLION shares outstanding. The stock will NOT (and CANNOT) “go to $.10.” (That would mean a $2 BILLION market cap… for a company with a mere $20 million in sales… and an incredibly daunting regulatory path ahead.) Do your own due diligence! CHUC should (and WILL) be trading at less than ½ penny ($0.005).
Completely agree.
Just a hunch.
Re today’s FDA filing mentioned below: You’ll probably recall that XXII’s proposed VLN advertisements, included in their MRTP application, were a pain point during the TPSAC meeting. Just guessing here, but I could see XXII deciding simply to offer to remove the “controversial” ads in order also to remove the (hopefully) last obstacle to the FDA granting MRTP approval. I’d view this filing/amendment as a very, very positive development.
You’ll probably recall that XXII’s proposed VLN advertisements, included in their MRTP application, were a pain point during the TPSAC meeting. Just guessing here, but I could see XXII deciding simply to offer to remove the “controversial” ads in order also to remove the (hopefully) last obstacle to the FDA granting MRTP approval. I’d view this filing/amendment as a very, very positive development.
I think ultimately that was a political decision. My personal view is that I’d trust Trump to “do the right thing” about as far as I could throw him; even if he is/was “anti-smoking”, once Big Tobacco’s lobbyists got to the Trump Administration, Joe Grogan et al were more than ready to do their bidding and sideline the nicotine mandate. I like our chances much more under Biden, Harris, Becerra, Woodcock/Sharpless, Zeller, etc. - plus all of the Democrat Senators and Congressmen and Congresswomen who in the past have indicated their strong support for the nicotine mandate.
Fraudsters were out in force again last Friday… Announcing that “CHUC has received FDA approval!” was an outright Pump and Dump LIE. Shamelessly, the liars are trying to dupe new bagholders into bailing them out of their losing CHUC investments. FDA decision (positive or negative) isn’t coming until the fall. No earnings report for at least another month. Realistic end-of-year price target: Less than ½ penny ($0.005).
Bradley Woods just published a new analyst report today with a new price target for XXII shares of $7 (excerpt below). $7 seems low to me - this looks more like $20 following MRTP approval. (Note: as far as I’m aware, the company has no current plan to raise more capital).
“Raise Price Target to $7.00
We reiterate our Buy recommendation on 22nd Century and raise our price target to $7.00.
The Federal Reserve’s accommodative monetary has resulted in an increase in equity market valuations via lower implicit discount rates and created an opportunity, for small cap companies in particular, to tap the equity markets and provide long-term growth capital at attractive prices. This has lowered the risk premium of the small-cap market in general, as financing risk for many has diminished, at least for those willing to take advantage of today’s liquidity.
President Biden’s rescission of President Trump’s Executive order EO 13771 sets the framework for a more activist FDA and bodes well for the shares. Also, marijuana legalization in the U.S. is gathering momentum and this can be a source of significant value for 22nd Century via its investment in Panacea and relationship with KeyGene.
We expect approval of the MRTP to be a significant catalyst for the shares and also believe it is a precursor to the nicotine mandate the FDA explored with an Advanced Notice of Proposed Rulemaking (ANPRM) published in March 2018. The ANPRM was on the HHS Unified Regulatory Agenda in Fall 2018 and Spring 2019 but was dropped in the Fall 2019 agenda indicating the FDA was putting the process on the shelf, but the reasons were not articulated publicly. The goal is not dead, at least with FDA leadership, as indicated by Mitchell Zeller, Director of the FDA’s Center for Tobacco Products at the Tobacco and Nicotine Products Regulation and Policy Conference held in October 2020. We assume regulatory policy in a Biden Administration will be more active than it was under the Trump Administration which has required incremental regulations to be offset by the elimination of two prior regulations and sets a regulatory cost cap on each agency.
22nd Century remains committed to a commercial launch of VLN cigarettes within 90 days of MRTP approval and is in active discussion with retailers and distributors. The initial stage will be to select markets to test customer acceptance, pricing, and marketing. This will continue for a few months and recalibrated as the roll-out expands.
Rating Buy Price Target $7.00
February 22, 2021
Not sure what “immediate” means here, but approval is imminent.
I muted GIO and Ezra years ago, and every time I happen to catch a reference to one of their posts within your (or others’) posts it reminds me of what a good decision it was to mute them both years ago. I’d recommend you do the same - life’s too short - it’s not worth engaging with some people.
Sort of interesting, but ENDS PMTA review is a completely different animal from FDA’s review of XXII’s MRTP application. I’m confident FDA will be approving XXII’s MRTP soon.
Someone posted last night: “weird thing is that there are no company updates and no news and… this bounced 60-70%” last month. It IS weird, isn’t it? Can you say pump n dump?! Certain individuals took advantage of 90% of other shareholders with lies about a February earnings report and an “imminent” FDA decision (which isn’t coming until the fall). Sadly, investors who paid more than $.005 for CHUC are bagholders.
Sure enough: All the PUMPERS who lied about a CHUC earnings report… and about an “imminent” FDA decision… are gone now. Most already DUMPED. Only Bagholders remain.
CHUC has more than 20 BILLION shares outstanding. And an incredibly daunting regulatory path ahead. And a business that has been losing millions of dollars. Yet small investors are flying closer and closer to the flame… Do your own due diligence!
Yup - on the same page.
Great find on this article - interesting that, in the authors’ view, the FDA appears still to be committed to the reduced nicotine mandate - our XXII “grand slam”:
A Mixed Record - Tobacco Reporter
https://tobaccoreporter.com/2021/02/01/a-mixed-record/
A nice summary of FDA’s progress on their 2017 Comprehensive Plan to reduce smoking/nicotine addiction and their proposed reduced nicotine mandate (indicates that in the authors’ view, the FDA appears still to be committed to the reduced nicotine mandate):
A Mixed Record - Tobacco Reporter
https://tobaccoreporter.com/2021/02/01/a-mixed-record/
I agree. I think that was the FDA’s original intention - promote ENDs products as an off-ramp to combustible cigarettes, after inducing smokers to smoke less by mandating VLN. However, the FDA somewhat blew it by not regulating ENDs products strictly enough (very few studies of short/long-term health impacts; failure to regulate sales to kids), but rather assumed that the Big T/vaping/ENDs suppliers would “do the right thing” and not focus on addicting high-schoolers. So now the FDA is in a tough spot. ENDs products certainly seem to be “better” than combustible cigarettes on the spectrum of risk; however the FDA is playing catch-up now trying to ensure that those products are kept away from kids etc. I still think that the FDA knows that their initial 2-prong smoking cessation initiative is the right path to go down; they just hit a self-inflicted speed bump.
Regardless, I still think FDA wants to (and will) approve XXII’s MRTP soon, and that there’s a better than 60% chance that the VLN mandate will be placed back on the Unified Regulatory Agenda within the next 6 months.
Everyone should do their own dd… CHUC has (way) more than 20 BILLION shares outstanding. (Cringe.) That means today’s stock price already makes CHUC way, way overvalued. If the stock goes up 10X (and some on this board are calling for “1,000X” -- HEADSLAP), CHUC’s market cap would be bigger than the entire VAPE industry. (Yeah, right, that makes sense. Not!)
Do you think CHUC has a “CHEAP” stock price? Not when there are (WAY) more than 20 BILLION shares outstanding! CHUC’s market cap is VERY EXPENSIVE today. $.0025 (1/4 penny) is a fair price for CHUC; that’s a $50 million market cap… Pumpers are trying to get us to pay WAY MORE. Don’t be a BAGHOLDER!
CHUC traded at about 1/4 penny for the last 12 months then, on NO NEWS from the Company, fraudsters pumped CHUC shamelessly. Most have already dumped. Are you a bagholder?!
Pumpers have been trying to fool newbies… CHUC has ZERO near term catalysts. No earnings report this month. FDA decision (positive or negative) isn’t coming until the fall. This stock is WAY overbought. Get ready for the DUMP.
“Final PMTA Rule Offers No Help for Small Vape Industry” (see link below). This is VERY bad news for CHUC… “Small- and medium-sized manufacturers that submitted (PMT)applications last summer are likely to soon receive deficiency letter from the FDA, asking for expensive additional testing and additional work…” (Cringe.) https://vaping360.com/vape-news/107981/final-pmta-rule-offers-no-help-for-small-vape-industry/
Coming back again soon (this is from 2018) - but once MRTP approval is granted (our “home run”), HHS Sec. Becerra re-prioritizing the reduced nicotine mandate for combustible cigarettes is our “grand slam”:
FDA Seeks Public Comment on a Potential Product Standard to Lower Nicotine in Cigarettes to a Minimally or Non-Addictive Level | FDA
https://www.fda.gov/tobacco-products/ctp-newsroom/fda-seeks-public-comment-potential-product-standard-lower-nicotine-cigarettes-minimally-or-non
How Could Lowering Nicotine Levels in Cigarettes Change the Future of Public Health? | FDA
https://www.fda.gov/tobacco-products/public-health-education/how-could-lowering-nicotine-levels-cigarettes-change-future-public-health
For the newbies - a reminder of the FDA’s Ted Talk from last year:
https://www.ted.com/talks/mitch_zeller_the_past_present_and_future_of_nicotine_addiction?utm_campaign=tedspread&utm_medium=referral&utm_source=tedcomshare
I agree. I think we’re still significantly under the radar. Oh well - more and more people will be finding out about XXII in the coming weeks.
I don’t think the warrant exercise will negatively impact the share price. To the contrary, as the exercise will result in another $X million payment to the company, I’d think that would be viewed as a positive in that it adds even more cash to the amount they can use for their VLN rollout. (In any case, XXII is far from cash-strapped - they have a lot of cash in reserve to dedicate to the pending rollout, and the warrant exercise will give them even more cushion.)
Do you think CHUC has a “CHEAP” stock price? Not when there are (WAY) more than 20 BILLION shares outstanding! CHUC’s market cap is VERY EXPENSIVE today. $.0025 (1/4 penny) is a fair price for CHUC; that’s a $50 million market cap… the pumpers are trying to get us to pay 5-10 TIMES MORE. Don’t be a BAGHOLDER!
CHUC went up 300% over the last month... on NO NEWS from the Company! Do your own dd. See for yourself! Sadly, the ONLY thing behind CHUC's increased stock price has been PUMPERS on this board talking about: 1) A FAKE $.50 price target (just try finding an actual analyst report on CHUC's. It doesn't exist!). 2) An earnings report to be released today (It was NOT released today... and will NOT be released until late March! Call the Company and see for yourself.) and 3) An FDA decision "THIS month" (the FDA decision -- positive or negative -- isn't expected UNTIL THE FALL). Fraudsters have been pumping CHUC shamelessly... before they dump. Are you a bagholder?!
It's Friday...and NO CHUC earnings report. Like I said, the pumpers were lying. Earnings will not come out until the END OF MARCH. (Call the Company yourself to verify!) Even more importantly, an FDA decision will NOT be made this month... or next. It isn't expected UNTIL THE FALL. Pumpers have been manipulating CHUC's stock all month. Sorry to say: If you bought above $.005 (a half penny) you have been duped.
For those who are new to XXII, this diligence piece is excellent:
https://www.reddit.com/r/pennystocks/comments/kymmf6/great_dd_on_xxii_plant_biotech_company_working/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
There are now years of research that show that smoking reduced nicotine content cigarettes will help people to smoke less, including this significant study published by the @NEJM: bit.ly/38HnJzy.
Feb 2020 Letter from Rep. Pallone urging FDA to proceed with the Reduced Nicotine Mandate:
https://energycommerce.house.gov/newsroom/press-releases/pallone-urges-fda-to-proceed-with-setting-a-maximum-nicotine-level-in
Re-posting the recent The Atlantic article advocating for the re-prioritization of the FDA’s Reduced Nicotine Mandate. This would be kinda good for 22nd Century:
https://www.theatlantic.com/ideas/archive/2020/12/easy-way-to-quit-smoking/617305/
GME investors who bought in at $483, $383, $283, $183, and $83 are BAGHOLDERS. CHUC investors who bought in at $.047, $.037, $.027, and $.017 are BAGHOLDERS. Get out now... before we sink below .007. I'm calling it: CHUC is going back to its average pps (over the last year). About $.003.
Posters calling for a $.50 price target should realize: (i) a $.50 share price would mean a CHUC valuation of $14 BILLION, (ii) the ENTIRE vaping industry is only $3 billion! (iii) the analyst report with a $.50 price target is FAKE NEWS. THERE IS NO ANALYST REPORT ON CHUC!!!
Good company. Good management. But WAY, WAY too expensive. A $185MM market cap?!?!
Worst of all, the PACT act is VERY bad for CHUC. ??